Hanmi Pharmaceutical, the core operating company of Hanmi Science, announced on Wednesday that it has signed an exclusive distribution agreement with Mexican pharmaceutical company Laboratorios Sanfer for its GLP-1 obesity drug efpeglenatide and its Dapalon-lineup diabetes treatment combination products
Currently in the UK, injectable GLP-1 receptor agonists such as semaglutide (Ozempic) and dulaglutide (Trulicity) are well-established treatments recommended by NICE (NG28) for specific indications in type 2 diabetes management, with some formulations also approved for weight management
This is rarely a concern for the average person taking standard doses, but it highlights why "more" is not always "better." The goal is to maintain a steady, balanced intake of both to support a healthy internal environment
Combined with metformin, personalized tirzepatide therapy creates a fully customized weight management plan based on your unique biology
The snack cupboard may shrink, but whats inside is premiumizing - think protein, gut health, and gentle on your stomach. 3
The lower limit of quantification for the analytical assay was 50 ng ml 1